group.bmj.com on June 20, 2017 -Published by http://jmg.bmj.com/ Downloaded from (father) and 62 (mother). Then the probability that, given that one or other was a carrier, both would die healthy is 7 %, a fairly substantial figure. So it is not implausible to suppose that one of them did carry the gene. Evidently, to be sure that the disease was not inherited, all relatives-sibs, uncles, aunts, parents, and grandparents-must have had clean bills of neurological health to advanced ages in the majority of cases.
BIAS
All the above factors, and others, can cause bias in the ascertainment of sporadic cases and bias in determining their genetic nature. Firstly, there is bias against the demonstration of sporadic cases. By definition such cases cannot be found by family searching, so that one efficient method of ascertainment cannot be used. Also, to prove a sporadic case we require good evidence that Huntington's chorea has not previously occurred in the family, together with proof of legitimacy and reliable diagnosis. Finally, to prove a new mutation, it is essential to have evidence that the disease is inherited, through the diagnosis of affected offspring. This is only likely to be possible retrospectively.
On the other hand, a person with worrying neurological symptoms, but no inkling that they might have an incurable inherited disorder, may be more likely to seek medical advice than a member of an afflicted family. Since family histories are usually sought only when a diagnosis of Huntington's chorea seems likely on other grounds, these patients may be as likely to enter a survey as any other proband.
Lastly, there is diagnostic bias. The elimination of this depends largely on the professional standards of the research worker. In particular it is important that in a survey as many patients as possible, and all case notes, are examined by a specialist in the disease. Stevens, 6 for example, reported 29 Prevalence seems to be much lower in Japanese and Negro populations.
(ii) Criteria for including sporadic cases vary.
(a) Both parents healthy to older than 60; otherwise classic picture; no other familial evidence.
(b) Both parents died healthy at any age; otherwise classic picture; no other familial evidence.
(c) Wendt (see table 1) , with a 15-year interval on average between onset and death, and mean onset at about the age of 40,4 the incidence must be 3 to 7 x 10-6. Then, using the higher incidence figure, choreic births form about 7x10-6/1.4x10-2= 5xlO-4 of all births. If 1 in 500 of these are new mutants, the mutation rate is about 1 x 10-6. If 1 in 1000 are new mutants and we take the lower incidence figure, the rate is nearer 10-7. These figures are on the low side but broadly speaking comparable with previous estimates (see table 1 ).
Comparative data
Stephenson and Kerr29 considered the available evidence on sex linked mutations in man, concluding that the average mutation rate at a given locus was likely to be substantially less than 10-6 per gamete, with considerable variation above and below this figure. The range of mutation rates suggested above for the Huntington's chorea locus fits this picture, which is also in general agreement with data from mice and Drosophila (see, for example, Dobzhansky3O); but in any species the range of rates is so wide that it would be very surprising to find substantial disagreement. Any estimate between 10-9 and 1o-5 would be reasonable.
Conclusions
Our fundamental belief is that it is wrong to tell the relatives of a patient suffering from a remarkably unpleasant, slow, progressive neurological disease, for which medical science can do virtually nothing, that they run a risk of also developing the disease, unless it is proven that they do so. The proportion of cases in which this question arises is, of course, irrelevant to this position. We believe that this review shows two things. Firstly, the number of cases in which a family history is genuinely negative is smaller than commonly believed; we have given reasons why this may be so. Secondly, the mutation rate to Huntington's chorea is very small in proportion to the total number of cases. Lastly, we wish to reiterate our belief that the label attached to patients who seem to suffer from a Huntington's chorea-like syndrome, but in whom the heritable nature of the disease is not proven, should not be Huntington's chorea but a neutral label.
